World Hepatitis Day 2026: Breaking Down Barriers to Eliminate a Silent Killer

Every 30 seconds, someone in the world dies from hepatitis-related complications—yet this disease is preventable, treatable, and in many cases, curable. 

World Hepatitis Day, observed annually on July 28th, marks a critical moment in the global fight against viral hepatitis. The date honors the birthday of Dr. Baruch Blumberg, the Nobel Prize-winning scientist who discovered the hepatitis B virus and developed its first vaccine. 

The 2026 theme, “Hepatitis: Let’s Break It Down,” is more than a slogan—it’s an urgent call to action for governments, healthcare providers, and individuals to dismantle the financial, social, and systemic barriers blocking access to life-saving prevention, testing, and treatment services. 

The Silent Epidemic: Understanding the Hepatitis Crisis

Viral hepatitis is an inflammation of the liver that can lead to severe liver disease, cirrhosis, and liver cancer. The five main types—A, B, C, D, and E—vary in transmission and severity, but hepatitis B (HBV) and hepatitis C (HCV) account for the vast majority of global deaths and are the primary focus of elimination efforts. 

The Global Burden: Alarming Statistics

The numbers paint a stark picture of a public health emergency:

• 287 million people were living with chronic hepatitis B or C in 2024. 

• 1.34 million deaths occurred in 2024 due to viral hepatitis—exceeding deaths from HIV. 

• 1.8 million new infections occur every year—that’s nearly 5,000 new cases daily. 

• Only 45% of babies received the hepatitis B vaccine within 24 hours of birth in 2024, leaving millions vulnerable to lifelong infection. 

• Fewer than 5% of people with chronic hepatitis B are receiving treatment. 

• Approximately 50% of people who inject drugs have been infected with hepatitis C. 

Ten countries—including China, India, Indonesia, Nigeria, and South Africa—account for nearly 70% of global hepatitis B-related deaths. 

Breaking Down Barriers: The 2026 Theme Explained

The “Let’s Break It Down” campaign targets three critical obstacles that have hindered progress for decades: 

1. Dismantling Stigma and Discrimination

Stigma remains one of the most powerful barriers to hepatitis elimination. Fear of judgment prevents people from getting tested, while discrimination in healthcare settings discourages treatment. 

The campaign calls for:

• Sharing accurate information to combat myths

• Amplifying voices of people affected by hepatitis

• Community-led solutions that leave no one behind 

2. Simplifying Service Delivery

Many health systems make accessing hepatitis care unnecessarily complex. Testing and treatment are often siloed in specialized centers, creating barriers for rural and underserved populations. 

Solutions include:

• Decentralizing services to primary care and district health centers

• Integrating hepatitis services with maternal health, HIV, and NCD programs

• Adopting simplified testing and treatment protocols 

3. Expanding Equitable Access

The tools to eliminate hepatitis exist, but they don’t reach everyone. Effective vaccines, curative treatments for hepatitis C, and lifelong therapies for hepatitis B are available—yet millions remain undiagnosed and untreated. 

Key priorities:

• Embedding hepatitis services in universal health coverage

• Reducing out-of-pocket expenses

• Reaching vulnerable populations, including people who inject drugs, incarcerated individuals, and migrant communities 

The Tools We Already Have: Science is on Our Side

This is what makes the hepatitis crisis so frustrating—and so solvable.

Vaccines

• Hepatitis B vaccine is highly effective and recommended for all newborns, ideally within 24 hours of birth. This vaccine also protects against hepatitis D. 

• Hepatitis A and E also have effective vaccines or prevention strategies. 

Curative Treatments

• Hepatitis C can be cured in over 95% of cases with a 12-week course of direct-acting antivirals (DAAs). The cost has dropped dramatically, with a $60 treatment course now available through the Global Fund. 

• Hepatitis B can be effectively managed with antiviral medications that reduce liver cancer risk by half. 

Prevention

• Safe injection practices and harm reduction services (sterile needles, opioid substitution therapy) prevent transmission. 

• Timely hepatitis B birth-dose vaccination prevents mother-to-child transmission. 

Call to Action: What You Can Do

Everyone has a role to play in breaking down barriers to hepatitis elimination. 

For the Public:

• Get tested for hepatitis B and C—knowing your status is the first step to prevention and treatment. 

• Talk to your healthcare provider about risk factors and testing.

• Promote hepatitis B vaccination for newborns and children.

• Share accurate information and help stop stigma. 

For Communities and Civil Society:

• Advocate for political commitment and financing for hepatitis programs.

• Support community-led solutions and amplify affected voices.

• Combat stigma and discrimination through education. 

For Policymakers and Governments:

• Lead and fund awareness campaigns linking hepatitis to liver cancer prevention.

• Expand hepatitis B birth-dose vaccination, safe blood practices, and harm reduction.

• Scale up affordable, decentralized testing and treatment integrated into primary care.

• Embed hepatitis services in universal health coverage and national insurance schemes. 

For Healthcare Professionals:

• Encourage hepatitis testing in all healthcare settings.

• Take hepatitis training to increase testing rates and combat stigma.

• Partner with community groups to improve linkage to care. 

Progress and Hope: The Path to 2030

Elimination is achievable—and progress is being made.

Global successes include:

• Hepatitis B infections among children under five have dropped to 0.6%, with 85 countries achieving the 2030 target. 

• Childhood hepatitis B vaccination has prevented over 22 million deaths since 1990. 

• Countries like Egypt have reduced hepatitis C prevalence from 10% to 0.4% through large-scale screening and treatment. 

But the world is off-track to meet the 2030 elimination targets.  We must accelerate action now—invest in testing, expand access to treatment, and ensure no one is left behind.

Conclusion: Break It Down Together

World Hepatitis Day 2026 is a reminder that we have the tools, the science, and the knowledge to eliminate hepatitis as a public health threat. What we need now is political will, sustained investment, and collective action to break down the barriers holding us back.

This July 28th, take action:

• Get tested.

• Talk about hepatitis openly.

• Advocate for change.

• Support those affected.

Together, we can break it down and build a hepatitis-free future.